These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 11732147

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cerebrospinal fluid investigations in tuberculous meningitis.
    Donald PR, Schoeman JF, Cotton MF, van Zyl LE.
    Ann Trop Paediatr; 1991; 11(3):241-6. PubMed ID: 1719923
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis.
    van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH, Springer P, Hoepelman AI, Geelen SP, Kimpen JL, Schoeman JF.
    Pediatr Infect Dis J; 2004 Jul; 23(7):608-13. PubMed ID: 15247597
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Temporal evolution of cerebrospinal fluid following initiation of treatment for tuberculous meningitis.
    Patel VB, Burger I, Connolly C.
    S Afr Med J; 2008 Aug; 98(8):610-3. PubMed ID: 18928039
    [Abstract] [Full Text] [Related]

  • 10. Kinetics of T-cell-based assays on cerebrospinal fluid and peripheral blood mononuclear cells in patients with tuberculous meningitis.
    Park KH, Lee MS, Lee SO, Choi SH, Kim YS, Woo JH, Kang JK, Lee SA, Kim SH.
    Korean J Intern Med; 2014 Nov; 29(6):793-9. PubMed ID: 25378978
    [Abstract] [Full Text] [Related]

  • 11. Factors influencing the presentation and outcome of tuberculous meningitis in childhood.
    Faella FS, Pagliano P, Attanasio V, Rossi M, Rescigno C, Scarano F, Conte M, Fusco U.
    In Vivo; 2006 Nov; 20(1):187-91. PubMed ID: 16433051
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Dexamethasone adjunctive treatment for tuberculous meningitis.
    Girgis NI, Farid Z, Kilpatrick ME, Sultan Y, Mikhail IA.
    Pediatr Infect Dis J; 1991 Mar; 10(3):179-83. PubMed ID: 2041662
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid electrophoretic proteinograms in tuberculous and pyogenic meningitis.
    Phadke MA, Ashtekar SV, Kate SL, Sainani GS, Phadke MV, Mutalik GS.
    Indian Pediatr; 1975 Nov; 12(11):1169-72. PubMed ID: 1228133
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Changes in vitamin C and oxidative stress status during the treatment of tuberculous meningitis.
    Miric D, Katanic R, Miric B, Kisic B, Popovic-Katanic N, Nestorovic V.
    Int J Tuberc Lung Dis; 2013 Nov; 17(11):1495-500. PubMed ID: 24125457
    [Abstract] [Full Text] [Related]

  • 19. Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis.
    Colas RA, Nhat LTH, Thuong NTT, Gómez EA, Ly L, Thanh HH, Mai NTH, Phu NH, Thwaites GE, Dalli J.
    FASEB J; 2019 Nov; 33(11):13028-13039. PubMed ID: 31500466
    [Abstract] [Full Text] [Related]

  • 20. Extrapulmonary tuberculosis: tuberculous meningitis new developments.
    Galimi R.
    Eur Rev Med Pharmacol Sci; 2011 Apr; 15(4):365-86. PubMed ID: 21608431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.